| Report ID |
178385 |
| Drug Identification Number |
02162849 |
| Brand name |
GLUCOPHAGE |
| Common or Proper name |
GLUCOPHAGE 850 mg |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
METFORMIN HYDROCHLORIDE |
| Strength(s) |
850MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL
ORAL |
| Packaging size |
100 |
| ATC code |
A10BA |
| ATC description |
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
|
| Actual start date |
2022-12-13 |
| Estimated end date |
2023-08-31 |
| Actual end date |
2023-08-31 |
| Shortage status |
Resolved |
| Updated date |
2023-09-01 |
| Company comments |
Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
